Concepedia

Xilu Wang

XW

Statistics

Publications

26

Citations

2.2K

H-Index

19

Active since

1996

Affiliations

Abbott Fund(Current)

AbbVie (United States)

Abbott (United Kingdom)

Rutgers, The State University of New Jersey

University of Wisconsin–Madison

Xilu Wang is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1996–2024

26

Publications

26

Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity

Zhi‐Fu Tao, Lisa Hasvold, Le Wang et al. · ACS Medicinal Chemistry Letters · 2014 · 331 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL

Milan Bruncko, Thorsten Oost, Barbara Belli et al. · Journal of Medicinal Chemistry · 2007 · 295 citations · Full text

Pharmacy, Oncology, Pharmacology +14

Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins

Cheol‐Min Park, Milan Bruncko, Jessica Adickes et al. · Journal of Medicinal Chemistry · 2008 · 293 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x <sub>L</sub> from NMR and Parallel Synthesis

Andrew M. Petros, Jürgen Dinges, David J. Augeri et al. · Journal of Medicinal Chemistry · 2005 · 293 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

Milan Bruncko, Le Wang, George S. Sheppard et al. · Journal of Medicinal Chemistry · 2015 · 152 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–5 of 26